Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon versus diazoxide for neonatal hypoglycaemia in infants of diabetic mothers
ACTRN12617001473358Phase 4Recruiting
- Sponsor
- Dr Lydia Kennedy
- Start
- Feb 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of glucagon and diazoxide in Neonatal hypoglycemia (2 arms), sponsored by Dr Lydia Kennedy. Primary endpoint: Treatment failure in allocated study arm. Started Feb 2018; status: recruiting.
02
Drugs
glucagondiazoxide
03
Conditions
Neonatal hypoglycemia
Beyond the preview
Go deeper on ACTRN12617001473358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001473358.